ACR 50% improvement · patients with rheumatoid arthritis in adults
Certolizumab pegol 200 mg sc (with or without MTX) leads to higher ACR 50% improvement compared with placebo (with or without MTX) (high certainty).
1 finding from 1 review
Intervention not reported
ACR 50% improvement ( · patients with Rheumatoid arthritis
The intervention showed no clear difference in ACR 50% improvement ( (low certainty).
1 finding from 1 review
ACR 50% improvement · patients with rheumatoid arthritis
Abatacept (2 and 10mg/kg) + DMARDs/biologic probably leads to higher ACR 50% improvement compared with placebo + DMARDs/biologic (moderate certainty).
1 finding from 1 review
ACR50% improvement criteria · patients with rheumatoid arthritis
Tocilizumab 8 mg/kg + MTX/DMARD leads to higher ACR50% improvement criteria compared with placebo + MTX/DMARD (high certainty).
1 finding from 1 review
Intervention not reported
ACR 50% improvement ‐ not measured · patients with treating rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
ACR50 American College of Rheumatology improvement criteria · participants with rheumatoid arthritis and with partial response to MTX
The intervention probably leads to higher ACR50 American College of Rheumatology improvement criteria (moderate certainty).
1 finding from 1 review
Intervention not reported
ACR 50 American College of Rheumatology improvement criteria · patients with rheumatoid arthritis
The intervention probably leads to higher ACR 50 American College of Rheumatology improvement criteria (moderate certainty).
1 finding from 1 review
Intervention not reported
ACR50 American College of Rheumatology 50% improvement criteria · participants with rheumatoid arthritis and with a partial response to DMARDs
The intervention probably leads to higher ACR50 American College of Rheumatology 50% improvement criteria (moderate certainty).
1 finding from 1 review
Intervention not reported
Outcome: ACR50 ‐ American College of Rheumatology Improvement Criteria · participants with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found